webinar register page

Webinar banner
Role of Digitalization in Pharma Sector
COVID-19 has accelerated the pace of digitalization across industries including the pharmaceutical sector and the industry is now recognizing digital technology adoption and innovation as an essential item to drive growth.

The Indian Pharma sector is ranked third largest by volume in the global market and is currently valued at $41.7 billion and it is forecast to reach US $65 billion by 2024 and US $120 billion by 2030. Digital technologies like Artificial Intelligence (AI), Machine Learning (ML), 3D Printing, and Additive Manufacturing are helping Indian Pharmaceutical companies to step up R&D process, conducting tests in less time, improving efficiencies and compliances in manufacturing, and increasing profitability.

Key Discussion Points:
- Where do Indian pharmaceutical companies stand in terms of digitalization?
- Effective use of digital technologies by Indian pharmaceutical companies
- Does the Indian pharma industry need partnerships for the next stage of digital transformation?
- Technology investments required to achieve Pharma 4.0
- Developing skilled manpower to implement Pharma 4.0 in an integrated manner
- Achieving sustainability through digitalization

- Sanjay Verma, Group CIO & Vice President IT, Akums Drugs & Pharmaceuticals Ltd
- Manu Gupta, Vice President - IT, Cadila Pharmaceuticals Ltd
- Rahul Borse, Head IT, RPG Life Sciences Ltd
- Krishna Sai T, Associate Vice President - IT & SAP, Biocon Ltd
- Amit Saluja, Senior Director and Center Head, NASSCOM
- Pravin Prashant, Editor, Indian Pharma Post

Jun 24, 2022 03:00 PM in India

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: .